[Orbital myeloid sarcoma secondary to acute myeloblastic leukemia]

J Fr Ophtalmol. 2020 Jan;43(1):e15-e16. doi: 10.1016/j.jfo.2019.06.018. Epub 2019 Dec 5.

[Article in French]

Authors

J-B Ducloyer¹, M Ducloyer², B Tessoulin³, P Lebranchu⁴, J-B Deltour⁴

Affiliations

¹ Service d'ophtalmologique, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 01, France. Electronic address: Jeanbaptiste.ducloyer@chu-nantes.fr.
² Service de radiologie, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 01, France.
³ Service d'hématologie clinique, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 01, France.
⁴ Service d'ophtalmologique, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 01, France.

PMID: 31813551
DOI: 10.1016/j.jfo.2019.06.018

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Agents / therapeutic use
Bone Marrow Neoplasms / secondary
Diagnosis, Differential
Guinea
Humans
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / pathology*
Leukemic Infiltration / diagnosis
Leukemic Infiltration / drug therapy
Male
Orbit / diagnostic imaging
Orbit / pathology
Orbital Neoplasms / diagnosis*
Orbital Neoplasms / drug therapy
Orbital Neoplasms / secondary*
Recurrence
Remission Induction
Sarcoma, Myeloid / diagnosis*
Sarcoma, Myeloid / drug therapy
Sarcoma, Myeloid / pathology

Substances

Antineoplastic Agents